These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19912648)

  • 1. Modulation of experimental autoimmune encephalomyelitis by endogenous annexin A1.
    Paschalidis N; Iqbal AJ; Maione F; Wood EG; Perretti M; Flower RJ; D'Acquisto F
    J Neuroinflammation; 2009 Nov; 6():33. PubMed ID: 19912648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
    Abad C; Jayaram B; Becquet L; Wang Y; O'Dorisio MS; Waschek JA; Tan YV
    J Neuroinflammation; 2016 Jun; 13(1):169. PubMed ID: 27357191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
    Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
    J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance.
    Álvarez-Sánchez N; Cruz-Chamorro I; López-González A; Utrilla JC; Fernández-Santos JM; Martínez-López A; Lardone PJ; Guerrero JM; Carrillo-Vico A
    Brain Behav Immun; 2015 Nov; 50():101-114. PubMed ID: 26130320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis.
    McLaughlin PJ; McHugh DP; Magister MJ; Zagon IS
    BMC Immunol; 2015 Apr; 16():24. PubMed ID: 25906771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis.
    Chen SJ; Wang YL; Lo WT; Wu CC; Hsieh CW; Huang CF; Lan YH; Wang CC; Chang DM; Sytwu HK
    Clin Exp Immunol; 2010 Nov; 162(2):210-23. PubMed ID: 21069936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LFA-1 Controls Th1 and Th17 Motility Behavior in the Inflamed Central Nervous System.
    Dusi S; Angiari S; Pietronigro EC; Lopez N; Angelini G; Zenaro E; Della Bianca V; Tosadori G; Paris F; Amoruso A; Carlucci T; Constantin G; Rossi B
    Front Immunol; 2019; 10():2436. PubMed ID: 31681316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis induced by adoptive transfer of Th1 cell lines.
    Lees JR; Iwakura Y; Russell JH
    J Immunol; 2008 Jun; 180(12):8066-72. PubMed ID: 18523270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of experimental autoimmune encephalomyelitis in the absence of c-Jun N-terminal kinase 2.
    Nicolson K; Freland S; Weir C; Delahunt B; Flavell RA; Bäckström BT
    Int Immunol; 2002 Aug; 14(8):849-56. PubMed ID: 12147621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD1-dependent regulation of chronic central nervous system inflammation in experimental autoimmune encephalomyelitis.
    Teige A; Teige I; Lavasani S; Bockermann R; Mondoc E; Holmdahl R; Issazadeh-Navikas S
    J Immunol; 2004 Jan; 172(1):186-94. PubMed ID: 14688325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis.
    Lee JK; Kannarkat GT; Chung J; Joon Lee H; Graham KL; Tansey MG
    J Neuroinflammation; 2016 Feb; 13():24. PubMed ID: 26831924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
    Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
    J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
    Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
    Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased severity of experimental allergic encephalomyelitis in lyn-/- mice in the absence of elevated proinflammatory cytokine response in the central nervous system.
    Du C; Sriram S
    J Immunol; 2002 Mar; 168(6):3105-12. PubMed ID: 11884485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical requirement of CD11b (Mac-1) on T cells and accessory cells for development of experimental autoimmune encephalomyelitis.
    Bullard DC; Hu X; Schoeb TR; Axtell RC; Raman C; Barnum SR
    J Immunol; 2005 Nov; 175(10):6327-33. PubMed ID: 16272284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node-derived donor encephalitogenic CD4+ T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet.
    Cravens PD; Hussain RZ; Zacharias TE; Ben LH; Herndon E; Vinnakota R; Lambracht-Washington D; Nessler S; Zamvil SS; Eagar TN; Stüve O
    J Neuroinflammation; 2011 Jun; 8():73. PubMed ID: 21702922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pitavastatin ameliorates autoimmune neuroinflammation by regulating the Treg/Th17 cell balance through inhibition of mevalonate metabolism.
    Prado DS; Damasceno LEA; Sonego AB; Rosa MH; Martins TV; Fonseca MDM; Cunha TM; Cunha FQ; Alves-Filho JC
    Int Immunopharmacol; 2021 Feb; 91():107278. PubMed ID: 33341737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proinflammatory bacterial peptidoglycan as a cofactor for the development of central nervous system autoimmune disease.
    Visser L; Jan de Heer H; Boven LA; van Riel D; van Meurs M; Melief MJ; Zähringer U; van Strijp J; Lambrecht BN; Nieuwenhuis EE; Laman JD
    J Immunol; 2005 Jan; 174(2):808-16. PubMed ID: 15634902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection with Mycobacterium bovis BCG diverts traffic of myelin oligodendroglial glycoprotein autoantigen-specific T cells away from the central nervous system and ameliorates experimental autoimmune encephalomyelitis.
    Sewell DL; Reinke EK; Co DO; Hogan LH; Fritz RB; Sandor M; Fabry Z
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):564-72. PubMed ID: 12853387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental autoimmune encephalomyelitis induction in naive mice by dendritic cells presenting a self-peptide.
    Weir CR; Nicolson K; Bäckström BT
    Immunol Cell Biol; 2002 Feb; 80(1):14-20. PubMed ID: 11869358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.